Related Experiment Video
Updated: Jan 7, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Sleep in Lennox-Gastaut Syndrome: A Scoping Review
1Division of Child Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Sleep disturbances are common in Lennox-Gastaut syndrome (LGS), impacting seizure control and cognition. This review highlights disrupted sleep architecture and circadian rhythms, suggesting sleep interventions may be a key therapeutic target for LGS.
Area of Science:
- Neurology
- Sleep Medicine
- Epileptology
Background:
- Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy with significant cognitive impairment.
- Sleep disturbances are highly prevalent in LGS, negatively impacting quality of life.
- Existing research lacks a comprehensive analysis of sleep architecture, microstructure, breathing, and circadian regulation in LGS.
Purpose of the Study:
- To conduct a scoping review of current evidence on sleep abnormalities in Lennox-Gastaut syndrome.
- To identify critical knowledge gaps regarding sleep in LGS.
- To establish priorities for future research into LGS sleep disturbances.
Main Methods:
- Conducted a scoping review following PRISMA-ScR guidelines, searching PubMed, Embase, Ovid, and ClinicalTrials.gov.
- Included observational and interventional studies using polysomnography, video-EEG, actigraphy, or sleep questionnaires from inception to October 2025.
- Synthesized data narratively due to heterogeneity and assessed methodological quality using Joanna Briggs Institute (JBI) checklists.
Main Results:
- Eleven studies (1986-2025) involving 5-16 LGS participants each were included, primarily small observational studies.
- Individuals with LGS showed disrupted sleep architecture (reduced REM sleep, fragmented NREM, attenuated spindles) and elevated cyclic alternating pattern (CAP) rates.
- Sleep-disordered breathing (SDB) and circadian rhythm dysregulation were common, with potential links to seizures and altered melatonin/cortisol profiles.
Conclusions:
- Sleep is profoundly disrupted in LGS at macrostructural and microstructural levels.
- These sleep abnormalities may worsen seizure burden, cognitive deficits, and SUDEP risk.
- Larger prospective studies integrating polysomnography, wearables, and interventions are needed to explore therapeutic potential.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Narcolepsy
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

